Alliance Integrated Metaliks Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 8, 2025, 10:58 pm

Competitors of Alliance Integrated Metaliks Ltd

All Competitor Stocks of Alliance Integrated Metaliks Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:05 am

Below is a detailed analysis of the quarterly data for Alliance Integrated Metaliks Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 28.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 12.00 Cr..
• For Expenses, as of Jun 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 23.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 11.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is 24.00%. The value appears strong and on an upward trend. It has increased from 17.00% (Mar 2025) to 24.00%, marking an increase of 7.00%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Interest, as of Jun 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -21.00 Cr.. The value appears to be declining and may need further review. It has decreased from -19.00 Cr. (Mar 2025) to -21.00 Cr., marking a decrease of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -21.00 Cr.. The value appears to be declining and may need further review. It has decreased from -19.00 Cr. (Mar 2025) to -21.00 Cr., marking a decrease of 2.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.52. The value appears to be declining and may need further review. It has decreased from -0.48 (Mar 2025) to -0.52, marking a decrease of 0.04.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:04 pm

Growth

Last Updated: September 5, 2025, 2:11 pm

Balance Sheet

Last Updated: July 25, 2025, 1:56 pm

Below is a detailed analysis of the balance sheet data for Alliance Integrated Metaliks Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2024) to 40.00 Cr., marking an increase of 27.00 Cr..
• For Reserves, as of Mar 2025, the value is -303.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -204.00 Cr. (Mar 2024) to -303.00 Cr., marking a decline of 99.00 Cr..
• For Borrowings, as of Mar 2025, the value is 251.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 258.00 Cr. (Mar 2024) to 251.00 Cr., marking a decrease of 7.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 346.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 277.00 Cr. (Mar 2024) to 346.00 Cr., marking an increase of 69.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 333.00 Cr.. The value appears to be improving (decreasing). It has decreased from 345.00 Cr. (Mar 2024) to 333.00 Cr., marking a decrease of 12.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 188.00 Cr.. The value appears to be declining and may need further review. It has decreased from 217.00 Cr. (Mar 2024) to 188.00 Cr., marking a decrease of 29.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 144.00 Cr.. The value appears strong and on an upward trend. It has increased from 128.00 Cr. (Mar 2024) to 144.00 Cr., marking an increase of 16.00 Cr..
• For Total Assets, as of Mar 2025, the value is 333.00 Cr.. The value appears to be declining and may need further review. It has decreased from 345.00 Cr. (Mar 2024) to 333.00 Cr., marking a decrease of 12.00 Cr..

However, the Borrowings (251.00 Cr.) are higher than the Reserves (-303.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Alliance Integrated Metaliks Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 18, the value is -180.86. This value is below the healthy minimum of 5. It has increased from -181.80 (Mar 17) to -180.86, marking an increase of 0.94.
• For Diluted EPS (Rs.), as of Mar 18, the value is -180.86. This value is below the healthy minimum of 5. It has increased from -181.80 (Mar 17) to -180.86, marking an increase of 0.94.
• For Cash EPS (Rs.), as of Mar 18, the value is -27.94. This value is below the healthy minimum of 3. It has decreased from -20.94 (Mar 17) to -27.94, marking a decrease of 7.00.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is -521.83. It has decreased from -341.03 (Mar 17) to -521.83, marking a decrease of 180.80.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is -521.83. It has decreased from -341.03 (Mar 17) to -521.83, marking a decrease of 180.80.
• For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 71.27. It has decreased from 90.05 (Mar 17) to 71.27, marking a decrease of 18.78.
• For PBDIT / Share (Rs.), as of Mar 18, the value is 17.52. This value is within the healthy range. It has increased from 7.12 (Mar 17) to 17.52, marking an increase of 10.40.
• For PBIT / Share (Rs.), as of Mar 18, the value is -5.70. This value is below the healthy minimum of 0. It has increased from -16.09 (Mar 17) to -5.70, marking an increase of 10.39.
• For PBT / Share (Rs.), as of Mar 18, the value is -59.54. This value is below the healthy minimum of 0. It has increased from -65.02 (Mar 17) to -59.54, marking an increase of 5.48.
• For Net Profit / Share (Rs.), as of Mar 18, the value is -51.16. This value is below the healthy minimum of 2. It has decreased from -44.15 (Mar 17) to -51.16, marking a decrease of 7.01.
• For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is -180.86. This value is below the healthy minimum of 2. It has increased from -181.80 (Mar 17) to -180.86, marking an increase of 0.94.
• For PBDIT Margin (%), as of Mar 18, the value is 24.58. This value is within the healthy range. It has increased from 7.90 (Mar 17) to 24.58, marking an increase of 16.68.
• For PBIT Margin (%), as of Mar 18, the value is -7.99. This value is below the healthy minimum of 10. It has increased from -17.87 (Mar 17) to -7.99, marking an increase of 9.88.
• For PBT Margin (%), as of Mar 18, the value is -83.55. This value is below the healthy minimum of 10. It has decreased from -72.20 (Mar 17) to -83.55, marking a decrease of 11.35.
• For Net Profit Margin (%), as of Mar 18, the value is -71.78. This value is below the healthy minimum of 5. It has decreased from -49.03 (Mar 17) to -71.78, marking a decrease of 22.75.
• For NP After MI And SOA Margin (%), as of Mar 18, the value is -253.77. This value is below the healthy minimum of 8. It has decreased from -201.89 (Mar 17) to -253.77, marking a decrease of 51.88.
• For Return on Networth / Equity (%), as of Mar 18, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 17) which recorded 0.00.
• For Return on Capital Employeed (%), as of Mar 18, the value is -4.56. This value is below the healthy minimum of 10. It has increased from -5.07 (Mar 17) to -4.56, marking an increase of 0.51.
• For Return On Assets (%), as of Mar 18, the value is -37.71. This value is below the healthy minimum of 5. It has decreased from -28.51 (Mar 17) to -37.71, marking a decrease of 9.20.
• For Long Term Debt / Equity (X), as of Mar 18, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 17) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 18, the value is -0.12. This value is within the healthy range. It has increased from -0.18 (Mar 17) to -0.12, marking an increase of 0.06.
• For Asset Turnover Ratio (%), as of Mar 18, the value is 0.11. It has decreased from 0.12 (Mar 17) to 0.11, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 18, the value is 0.31. This value is below the healthy minimum of 1.5. It has decreased from 0.38 (Mar 17) to 0.31, marking a decrease of 0.07.
• For Quick Ratio (X), as of Mar 18, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.15 (Mar 17) to 0.10, marking a decrease of 0.05.
• For Inventory Turnover Ratio (X), as of Mar 18, the value is 0.49. This value is below the healthy minimum of 4. It has decreased from 1.70 (Mar 17) to 0.49, marking a decrease of 1.21.
• For Interest Coverage Ratio (X), as of Mar 18, the value is 0.32. This value is below the healthy minimum of 3. It has increased from 0.14 (Mar 17) to 0.32, marking an increase of 0.18.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 0.04. This value is below the healthy minimum of 3. It has decreased from 0.09 (Mar 17) to 0.04, marking a decrease of 0.05.
• For Enterprise Value (Cr.), as of Mar 18, the value is 346.49. It has increased from 344.87 (Mar 17) to 346.49, marking an increase of 1.62.
• For EV / Net Operating Revenue (X), as of Mar 18, the value is 4.19. This value exceeds the healthy maximum of 3. It has increased from 3.30 (Mar 17) to 4.19, marking an increase of 0.89.
• For EV / EBITDA (X), as of Mar 18, the value is 17.03. This value exceeds the healthy maximum of 15. It has decreased from 41.72 (Mar 17) to 17.03, marking a decrease of 24.69.
• For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 1.71. This value is within the healthy range. It has increased from 1.55 (Mar 17) to 1.71, marking an increase of 0.16.
• For Price / BV (X), as of Mar 18, the value is -0.23. This value is below the healthy minimum of 1. It has increased from -0.41 (Mar 17) to -0.23, marking an increase of 0.18.
• For Price / Net Operating Revenue (X), as of Mar 18, the value is 1.71. This value is within the healthy range. It has increased from 1.55 (Mar 17) to 1.71, marking an increase of 0.16.
• For EarningsYield, as of Mar 18, the value is -1.48. This value is below the healthy minimum of 5. It has decreased from -1.30 (Mar 17) to -1.48, marking a decrease of 0.18.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness